Guardian Pharmacy Services (GRDN) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 5, 2026, with materials available online and by request.

• Stockholders of record as of March 13, 2026, are eligible to vote on key proposals.

Voting matters and shareholder proposals

• Election of two Class II directors to serve until the 2029 annual meeting.

• Advisory vote to approve executive compensation.

• Advisory vote on the frequency of future say-on-pay votes, with board recommending 1 year.

• Ratification of Ernst & Young LLP as independent auditor for 2026.

Board of directors and corporate governance

• Board recommends voting for all director nominees and for all proposals except the frequency of say-on-pay, where 1 year is recommended.